Chronic kidney disease in children and adolescents in Brunei Darussalam

Shi Ying Tan1, Lin Naing1, Aye Han1

  • 1Shi Ying Tan, Lin Naing, Universiti Brunei Darussalam, Brunei Darussalam BE 1410, Bandar Seri Begawan, Brunei.

Insights

Brunei has a high prevalence of pediatric chronic kidney disease (CKD), with glomerulonephritis being the most common cause. Non-glomerular diseases and female patients showed poorer growth outcomes.

Area of Science:

  • Pediatric Nephrology
  • Epidemiology
  • Chronic Kidney Disease (CKD)

Background:

  • Chronic kidney disease (CKD) in children presents unique challenges for growth and long-term health.
  • Understanding the epidemiology of pediatric CKD is crucial for public health initiatives.

Purpose of the Study:

  • To determine the epidemiology of pediatric chronic kidney disease (CKD) in Brunei.
  • To identify factors influencing growth and disease progression in these patients.

Main Methods:

  • A 10-year cross-sectional study (2004-2013) of all pediatric CKD patients (<18 years) in Brunei.
  • Data collection included demographics, anthropometrics, diagnoses, laboratory results, and blood pressure from clinical records.

Main Results:

  • High national prevalence (736 per million child population) and incidence (91 pcmp) of pediatric CKD.
  • Glomerulonephritis was the leading cause (69%), followed by congenital abnormalities (20%).
  • Significant association between non-glomerular diseases, adolescent, and female patients with poor growth.

Conclusions:

  • Brunei exhibits a high prevalence of pediatric CKD, predominantly caused by glomerulonephritis.
  • Early diagnosis is noted in congenital kidney diseases.
  • Factors such as non-glomerular disease type and patient demographics impact growth in pediatric CKD.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...